In Surprising Move, PTAB Tackles Tribal Immunity Head-On
Deciding it could review the validity of patents covering Allergan PLC's Restasis drug, the Patent Trial and Appeal Board tackled the issue of tribal sovereign immunity head-on, surprising legal experts who...To view the full article, register now.
Already a subscriber? Click here to view full article